3DKnee™ System vs. the MJS Knee System
|ClinicalTrials.gov Identifier: NCT00764803|
Recruitment Status : Terminated (Corporate decision to discontinue distribution of MJS Knee.)
First Posted : October 2, 2008
Last Update Posted : March 11, 2010
|Condition or disease||Intervention/treatment|
|Rheumatoid Arthritis Traumatic Arthritis Joint Disease Secondary to Osteoarthritis||Device: Encore 3DKnee™ system Device: Encore MJS™ Knee System|
|Study Type :||Observational|
|Actual Enrollment :||27 participants|
|Official Title:||Post-Market Study: The Efficacy of the 3DKnee™ System vs. the MJS Knee System|
|Study Start Date :||January 2008|
|Actual Primary Completion Date :||November 2009|
|Actual Study Completion Date :||December 2009|
Subjects who meet the indications for use and are implanted with the Encore MJS™ Knee System.
Device: Encore MJS™ Knee System
Subjects with rheumatoid arthritis, traumatic arthritis or osteoarthritis who were implanted with the Encore MJS™ Knee system and willing to participate in the study.
Subjects who meet the indications for and are implanted with the Encore 3DKnee™ system.
Device: Encore 3DKnee™ system
Subjects with rheumatoid arthritis, traumatic arthritis or osteoarthritis who were implanted with the Encore 3DKnee™ system and willing to participate in the study.
- The survivorship and efficacy of the Encore 3DKnee™ system with that of the Encore MJS™ Knee System [ Time Frame: 2 year ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00764803
|United States, California|
|Center for Excellence|
|Fresno, California, United States, 93710|
|Principal Investigator:||D. Kevin Lester, M.D.||Center for Excellence|